Ticker Symbol: FLDM
Fluidigm Corp
$4.86 - 20-11-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001162194
Company Profile
Fluidigm focuses on the most pressing needs in translational and clinical research, including cancer, immunology, and immunotherapy. Using proprietary CyTOF® and microfluidics technologies, it develops, manufactures, and markets multi-omic solutions to drive meaningful insights in health and disease, identify biomarkers to inform decisions, and accelerate the development of more effective therapies. Its customers are leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide. Together with them, the Company strives to increase the quality of life for all.
Sector: Manufacturing
Industry: Analytical Laboratory Instrument Manufacturing
Standard Industrial Classification Code (SIC code): 3826
Address: 7000 Shoreline Ct Ste 100
Website: www.fluidigm.com
CEO: Stephen Linthwaite
Tags:
- Health Technology
- Medical Specialties
- Manufacturing
- Analytical Laboratory Instrument Manufacturing
Pricing
Last Updated: April 1, 2022 03:00 PM EST
Previous Close: $3.77
Change:
$0.18
(
5.01%)
Days Range: $3.50 - $3.79
Beta: 1.31
52wk. High: $7.51
52wk. Low: $2.67
Ytd. Change 1.19%
50 Day Moving Average: $3.62
200 Day Moving Average: $4.30
Shares Outstanding: 76485632
Valuation
Market Cap: 28.8B
PE Ratio: -4.82
EPS (TTM): -0.7816
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A